Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Wong

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Developmental Cell|August 24, 2021
Spatial transcriptional mapping of the human nephrogenic programNils O Lindström, Rachel Sealfon, Xi Chen, et al.
Nature Communications|November 6, 2024
Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockadeMayra Cruz Tleugabulova, Sandra P Melo, Aaron Wong, et al.
Cell Metabolism|August 20, 2022
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosisYing Xi, Ryan LaCanna, Hsiao-Yen Ma, et al.
Circulation|May 14, 2024
Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)Heerajnarain Bulluck, Jun Hua Chong, Jennifer Bryant, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo A Ratsimandresy, Emma Doran, Hart S Dengler, et al.
Angiology|October 12, 2022
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical ReperfusionGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|February 11, 2023
Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Stephane Manzo-Silberman, Magdy Algowhary, et al.
Journal of Hypertension|October 24, 2024
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registryGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Journal of Clinical Medicine|May 27, 2026
Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Stephane Manzo-Silberman, Filippo Zilio, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Developmental Cell|August 24, 2021
Spatial transcriptional mapping of the human nephrogenic programNils O Lindström, Rachel Sealfon, Xi Chen, et al.
Nature Communications|November 6, 2024
Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockadeMayra Cruz Tleugabulova, Sandra P Melo, Aaron Wong, et al.
Cell Metabolism|August 20, 2022
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosisYing Xi, Ryan LaCanna, Hsiao-Yen Ma, et al.
Circulation|May 14, 2024
Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)Heerajnarain Bulluck, Jun Hua Chong, Jennifer Bryant, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo A Ratsimandresy, Emma Doran, Hart S Dengler, et al.
Angiology|October 12, 2022
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical ReperfusionGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|February 11, 2023
Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Stephane Manzo-Silberman, Magdy Algowhary, et al.
Journal of Hypertension|October 24, 2024
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registryGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Journal of Clinical Medicine|May 27, 2026
Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Stephane Manzo-Silberman, Filippo Zilio, et al.
Pageof 10